menu
    • menu

    Company profile for Ingenus Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ingenus Pharmaceuticals, LLC, is a privately-owned U.S. based pharmaceutical company. Our vision is to be recognized as the most innovative, collaborative and responsive company in the generic pharmaceutical industry. Ingenus believes lower-cost generic medication improves patient access and offsets overall healthcare costs. Since 2010, Ingenus has helped to make a difference by developing, manufacturing and commercializing q...
    Ingenus Pharmaceuticals, LLC, is a privately-owned U.S. based pharmaceutical company. Our vision is to be recognized as the most innovative, collaborative and responsive company in the generic pharmaceutical industry. Ingenus believes lower-cost generic medication improves patient access and offsets overall healthcare costs. Since 2010, Ingenus has helped to make a difference by developing, manufacturing and commercializing quality generic medications as cost effective solutions for patients, suppliers and stakeholders all across the healthcare continuum.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ingenus PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4190 Millennia Road Orlando, FL 32839
    Telephone
    Telephone
    (866) 321-5031
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ingenus.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/1492077/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ingenus Pharma Launches First Generic Equivalent To Premarin
    Ingenus Pharma Launches First Generic Equivalent To Premarin

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ingenus-pharmaceuticals-announces-fda-approval-and-launch-of-first-and-only-generic-equivalent-to-premarin-tablets-conjugated-estrogens-tablets-usp-302614676.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Ingenus`s Generics Dehydrated Alcohol Receives Approval in US
    Ingenus`s Generics Dehydrated Alcohol Receives Approval in US

    09 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219569

    FDA
    09 Jul 2025
    Share Share
    Dr. Reddy's shares rise as arm signs license agreement with Ingenus Pharma
    Dr. Reddy's shares rise as arm signs license agreement with Ingenus Pharma

    12 Jun 2024

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/stocks/dr-reddys-shares-rise-as-arm-signs-license-agreement-with-ingenus-pharmaceuticals-12747208.html

    MONEYCONTROL
    12 Jun 2024
    Share Share
    Ingenus Pharm's Generic Lifitegrast Receives Tentative Approval in US
    Ingenus Pharm's Generic Lifitegrast Receives Tentative Approval in US

    04 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215058

    FDA
    04 Jun 2024
    Share Share
    Ingenus' Generic Lifitegrast Receives Approval in the U.S.
    Ingenus' Generic Lifitegrast Receives Approval in the U.S.

    15 Feb 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215058

    FDA
    15 Feb 2023
    Share Share
    Enforcement Report - Week of October 26, 2022
    Enforcement Report - Week of October 26, 2022

    26 Oct 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-26-2022-89071.pdf

    FDA
    26 Oct 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search